The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that of its drugmaking peers.

On the heels of a data readout suggesting one of its cancer drugs could become a future blockbuster, Zymeworks is adopting a new strategy its CEO says will create “more consistent value for shareholde...

The company is working on T cell engagers and other multifunctional antibodies, led by a prospect it believes might be helpful treating the vast majority of colorectal cancer cases.

Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily pain. Doctors fear that’s bound to continue.

LB Pharmaceuticals, which has a schizophrenia medicine headed for late-stage testing, broke one of the longest droughts for large IPOs in years.

"I’ve never heard as many colleagues saying things like 'CDC is dead’ as I have today," an agency employee told STAT.

HHS is terminating a National Institutes of Health grant program that supports students from marginalized backgrounds in the biomedical sciences.

Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.

Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it harder to invest in companies advancing the technology.

The royalty aggregator’s proposed deals for HilleVax and Lava add to a pattern of “zombie” biotech buyouts this year as the sector’s struggles continue.

Many San Diego biotech firms are struggling to raise money, with the uncertainty exacerbated by the Trump administration’s disruptions to science.

The YouTube star wants her audiences — adults and children alike — to see the humanity of all people.

Judge denies bond for Guatemalan man worried about colon cancer as his condition appears to have grown worse in recent court hearings.

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over the past two decades.

FDA Commissioner Marty Makary reportedly attempted to reject KalVista Pharmaceuticals' drug application, sources said. An HHS spokesperson calls the claim 'totally false.'

The woman’s case is a worst-case scenario, according to advocates worried about the worsening state of domestic violence in the Houston region.

Recent policy changes around COVID-19 vaccines are already sowing chaos and confusion and restricting vaccine access — including for people who should still be eligible to receive them.

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a drug review, STAT has learned.

A dramatic pullback in public biotech investment catalyzed by economic and regulatory upheaval is putting even more stress on startups navigating a yearslong downturn.

Currently the vaccine is recommended for all people over 6 months of age.

Most people who take dietary or herbal supplements do so on their own, not under a doctor’s advice.

Lowery rose to prominence as a reporter and media thinker. Women in the industry say he engaged in sexual harassment and assault.

The research collaboration, under which Septerna will receive more than $200 million in upfront and near-term fees, is the latest deal Novo has struck to expand its obesity pipeline.

Vaccines and complex biologics may face greater headwinds as processes change at a short-staffed agency

Siren Biotechnology is trying to raise $5 million via the type of crowdfunding round that’s rarely used by young drugmakers.

The Supreme Court will hear a challenge of preventive health care coverage mandated by the Affordable Care Act. The ruling could affect millions of Americans.

The Houston Landing board has voted to shut down the nonprofit newsroom in the face of financial challenges. A story on its website states, “Although Houston Landing launched with significant seed fun...

It’s unclear what the move means for a related lawsuit that could dismantle protections for all people with disabilities.

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s premier testing laboratory for viral hepatitis, experts warned.

Health Secretary Robert F. Kennedy Jr. says he is committed to improving the Indian Health Service. Native American leaders have doubts. “It’s shameful,” one said.

“We, like so many others, have been forced to take steps to extend our cash runway,” said Tango’s CEO, citing the “extremely challenging financial markets.”

NOAA is under a mandate to slash its IT costs.

CDC officials are warning of delays and disruptions due to cuts to laboratory staff.

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed via rounds worth at least $100 million, which experts believe reflects a stra...

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Marks, an architect of Operation Warp Speed, warned that a recent measles outbreak shows how confidence in science and public health is being “undermined.”

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

Initially, Amvuttra’s annual list price will be nearly double the yearly cost of rival medicines from Pfizer and BridgeBio. But executives argue its “compelling and highly differentiated value” justif...

Employees are grappling with buyout offers as public health crises mount. “Somebody has to stay to help clean up the mess that they’re most likely going to make,” one said.

Including Nobel laureates, climate researchers, and parents of kids saved by groundbreaking drugs.

Last night, President Donald J. Trump highlighted many of the egregious examples of waste, fraud, and abuse funded by American taxpayers, including $8